Cargando…
The Neuroprotective Beta Amyloid Hexapeptide Core Reverses Deficits in Synaptic Plasticity in the 5xFAD APP/PS1 Mouse Model
Alzheimer’s disease (AD) is the most common cause of dementia in the aging population. Evidence implicates elevated soluble oligomeric Aβ as one of the primary triggers during the prodromic phase leading to AD, effected largely via hyperphosphorylation of the microtubule-associated protein tau. At l...
Autores principales: | Forest, Kelly H., Taketa, Ruth, Arora, Komal, Todorovic, Cedomir, Nichols, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075567/ https://www.ncbi.nlm.nih.gov/pubmed/33912008 http://dx.doi.org/10.3389/fnmol.2021.576038 |
Ejemplares similares
-
Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET
por: Oh, Se Jong, et al.
Publicado: (2018) -
Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer’s disease
por: Andersen, Jens V., et al.
Publicado: (2021) -
The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer’s disease pathology models
por: Lantz, Megan J., et al.
Publicado: (2023) -
Succinct Amyloid
and Nonamyloid Patterns in Hexapeptides
por: Keresztes, László, et al.
Publicado: (2022) -
New Positive TRPC6 Modulator Penetrates Blood–Brain Barrier, Eliminates Synaptic Deficiency and Restores Memory Deficit in 5xFAD Mice
por: Zernov, Nikita, et al.
Publicado: (2022)